Swiss giant drug producer Novartis (NVS) has found a new destination for its recent partnership spree. On Monday, Monte Rosa Therapeutics (GLUE), a Massachusetts-based biotech company, disclosed its second deal with Novartis, with Monte’s shares exploding over 50% in early trading to more than $7. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing …
Read More »Monte Rosa’s Stock (GLUE) Skyrockets on $5.7B Deal with Novartis
